|
Gutierrez A, Zeberio I, Penalver FJ, Martinez-Barranco P, Perez S, Morillo D, Martin X, Nicolas C, Ferrero A, Jimenez-Ubieto A, Bastos-Oreiro M, Davila-Valls J, Calle MV, Perez M, Rodriguez G, Alonso A, Garcia-Noblejas A, Sanchez Arguello D, Knight T, Fernandez A, Lopez J, Perez De Oteyza J, Gonzalez de Villambrosia S, Perez E, Marin A, Navarro MB, Fernandez R, Gomez P, Hueso JA, Penarrubia Ponce MJ, Bravo P, Garcia-Belmonte D, De La Nuez H, Nistal S, Abrisqueta P, Ibanez F, Palomera L, Donato E, Provencio A, Infante MS, Gonzalez-Barca E. Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO. Blood Adv. 2025 Oct 14;9(19):4924-4935. doi: 10.1182/bloodadvances.2025016661. PubMed PMID: 40668613; PubMed Central PMCID: PMC12508888.
AÑO: 2025; IF: 7.1
|
40668613
|
Rodenas-Quinonero I, Chen-Liang T, Martin-Santos T, Salar A, Fernandez-Gonzalez M, Celades C, Navarro JT, Martinez-Garcia AB, Andreu R, Balaguer A, Martin Garcia-Sancho A, Baile M, Lopez-Jimenez J, Marquet-Palomanes J, Teruel AI, Terol MJ, Benet C, Frutos L, Navarro JL, Una J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguilon-Gallego L, Sanchez-Blanco JJ, Perez-Ceballos E, Jerez A, Ortuno FJ. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Cancer Med. 2023 Mar;12(6):6536-6546. doi: 10.1002/cam4.5424. Epub 2022 Nov 13. PubMed PMID: 36373169; PubMed Central PMCID: PMC10067085.
AÑO: 2023; IF: 2.9
|
|
Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Martin Garcia-Sancho A, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice. Int J Hematol. 2022 Sep;116(3):381-392. doi: 10.1007/s12185-022-03367-z. Epub 2022 May 13. PubMed PMID: 35551632; PubMed Central PMCID: PMC9392694.
AÑO: 2022; IF: 2.1
|
|
Bastos Oreiro M, Martin R, Gomez P, Lopez Munoz N, Rodriguez A, Liebana M, Navarro B, Sanchez-Gonzalez B, Mari P, Perez de Oteiza J, Gutierrez A, Bento L, Domingo Domenech E, Vidal MJ, Del Campo R, Perez Ceballos E, Infante M, Roldan A, Garcia Belmonte D, Santero M, Sureda A, Sanz RG, On Behalf Of The Geltamo Group. SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers (Basel). 2021 May 17;13(10):2412. doi: 10.3390/cancers13102412. PubMed PMID: 34067616; PubMed Central PMCID: PMC8156414.
AÑO: 2021; IF: 6.575
|
|
Bastos-Oreiro M, Muntanola A, Panizo C, Gonzalez-Barca E, de Villambrosia SG, Cordoba R, Lopez JLB, Gonzalez-Sierra P, Terol MJ, Gutierrez A, Grande C, Ramirez MJ, Iserte L, Perez E, Navarro B, Gomez P, Salar A, Luzardo H, Lopez A, Del Campo R, Garcia-Belmonte D, Vida MJ, Infante M, Queizan-Hernandez JA, Novelli S, Moreno M, Penarrubia M, Gomez J, Domingo A, Donato E, Viguria MC, Lopez F, Rodriguez MJ, Pardal E, Noriega V, Andreu R, Penalver J, Martin A, Caballero D, Lopez-Guillermo A. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group. Ann Hematol. 2020 Apr;99(4):799-808. doi: 10.1007/s00277-020-03918-6. Epub 2020 Feb 20. PubMed PMID: 32076827.
AÑO: 2020; IF: 3.673
|